NR4A3 has been recognized as a tumor suppressor in various tumors.26 Consistent with this, our study revealed that NR4A3 is significantly downregulated in bladder cancer (BLCA) based on GEPIA database analysis, and its lower expression correlates with advanced TNM staging and poor patient survival. The gene discussed is NR4A3; the disease is bladder transitional cell carcinoma.